Business
Press Release Aug 18 2025
Marksans Pharma Limited has informed the Exchange regarding a press release dated August 18, 2025, titled "Marksans Pharma Limited s wholly owned subsidiary in UK, Relonchem Limited receives Marketing Authorization for its products.".
About this update from Marksans Pharma Limited
[{"type":"text","content":" Marksans Pharma Limited has informed the Exchange regarding a press release dated August 18, 2025, titled \"Marksans Pharma Limited s wholly owned subsidiary in UK, Relonchem Limited receives Marketing Authorization for its products.\". View Attachment","length":379,"tagName":"div"}]